Profound Medical

Profound Medical Inc. is a commercial-stage medical technology company headquartered in Mississauga, Ontario, Canada. The company develops and commercializes image-guided therapeutic systems designed to improve treatment options for prostate cancer and benign prostatic hyperplasia (BPH). Its flagship TULSA-PRO system uses real-time MRI guidance, robotic control, and transurethral therapeutic ultrasound to deliver customizable ablation of prostate tissue while helping physicians monitor and control treatment.

Profound Medical focuses on advancing precision-based, incision-free treatment approaches through medical device innovation, clinical research, physician education, and commercial partnerships. Its technology is designed to give clinicians greater control over treatment planning and energy delivery, with an emphasis on effective disease treatment and preservation of patients’ quality of life. The company serves hospitals, medical centers, urologists, radiologists, and other healthcare professionals involved in prostate disease management.